ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
0,00%
Dow Jones
39 118,86
-0,12%
DAX
18 234,12
0,00%
Brent Oil
85,535
0,50%
Bitcoin
63 348,84
1,08%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. NeoGenomics Inc (NEO)

  7. NeoGenomics Inc (NEO) Actualités

NEO

NeoGenomics (NEO)

NeoGenomics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NEO
DateHeureSourceTitreSymboleSociété
13/06/202422h08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NEONeoGenomics Inc
13/06/202414h00Business WireFort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer MonthNASDAQ:NEONeoGenomics Inc
04/06/202422h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
28/05/202414h05Business WireNeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment ManagementNASDAQ:NEONeoGenomics Inc
24/05/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NEONeoGenomics Inc
30/04/202413h30Business WireNeoGenomics Reports First Quarter 2024 ResultsNASDAQ:NEONeoGenomics Inc
18/04/202413h05Business WireNeoGenomics Announces Senior Leadership PromotionsNASDAQ:NEONeoGenomics Inc
09/04/202413h00Business WireNeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:NEONeoGenomics Inc
27/03/202413h30Business WireNeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual MeetingNASDAQ:NEONeoGenomics Inc
20/03/202412h00Business WireNeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) ReportNASDAQ:NEONeoGenomics Inc
04/03/202423h33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NEONeoGenomics Inc
01/03/202413h05Business WireNeoGenomics to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:NEONeoGenomics Inc
26/02/202422h15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NEONeoGenomics Inc
20/02/202422h23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NEONeoGenomics Inc
20/02/202422h05Business WireNeoGenomics Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:NEONeoGenomics Inc
20/02/202411h37IH Market NewsMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil Prices DipNASDAQ:NEONeoGenomics Inc
14/02/202416h04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NEONeoGenomics Inc
09/02/202421h17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NEONeoGenomics Inc
01/02/202413h05Business WireNeoGenomics Signs Working with Cancer Pledge in Support of EmployeesNASDAQ:NEONeoGenomics Inc
30/01/202413h05Business WireNeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024NASDAQ:NEONeoGenomics Inc
02/01/202413h05Business WireNeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:NEONeoGenomics Inc
06/11/202322h29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NEONeoGenomics Inc
08/07/202300h02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
03/06/202300h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NEONeoGenomics Inc
01/06/202322h30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NEONeoGenomics Inc
30/05/202322h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NEONeoGenomics Inc
09/05/202322h40Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NEONeoGenomics Inc
07/04/202322h07Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:NEONeoGenomics Inc
07/04/202322h04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NEONeoGenomics Inc
07/04/202322h02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NEONeoGenomics Inc
 Showing the most relevant articles for your search:NASDAQ:NEO

Dernières Valeurs Consultées

ASX
MQGJOZ
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés